ELGX Abuzz, ESPR Ahead Of Schedule, Tough Times For VIVO

Shares of Meridian Bioscience Inc. (VIVO) plunged over 20% on Wednesday as the company narrowed its profit and revenue forecasts for fiscal 2017.

from RTT - Biotech http://ift.tt/2km1MLr
via IFTTT